ProShare Advisors’s Fibrocell Science Inc. FCSC Stock Holding History

ProShare Advisors’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1,513	Closed	-$119K	–	2685
2014 Q1	$119K	Buy	+1,513	New	+$117K	﹤0.01%	2658
2013 Q4	–	Sell	-710	Closed	-$47K	–	2087
2013 Q3	$47K	Buy	+710	New	+$57.4K	﹤0.01%	2506

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCA

Catalyst Capital Advisors Huntington, New York $5.37B AUM 18.53% 1-Year Est. Return

BGA

Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

ProShare Advisors's FCSC Position: Q2 2014 in Review

ProShare Advisors sold out of Fibrocell Science Inc. (FCSC) in Q2 2014, closing a stake of 1,513 shares — an estimated $119K sold.

ProShare Advisors first reported a position in FCSC in Q3 2013 and held it in 2 quarters. The position peaked at $119K in Q1 2014. 44 funds tracked by Wall St. Rank hold FCSC as of Q2 2014.

ProShare Advisors reported no remaining Fibrocell Science Inc. position as of Q2 2014 after selling out during the quarter.
ProShare Advisors sold 1,513 Fibrocell Science Inc. shares in Q2 2014, an estimated $119K.
ProShare Advisors first reported a position in Fibrocell Science Inc. in Q3 2013 and held it in 2 quarters.
ProShare Advisors's Fibrocell Science Inc. position peaked at $119K in Q1 2014.
44 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2014.

Based on ProShare Advisors's 13F filing for Q2 2014, filed 8 Aug 2014.